BERLIN (AP) — German chemical and pharmaceutical company Bayer says it plans to invest some 5 billion euros ($5.6 billion) over the next decade in developing “additional methods to combat weeds.”
Friday’s announcement came as Bayer is engaged in legal battles in the U.S. in which plaintiffs claim that subsidiary Monsanto’s Roundup weed killer caused cancer. Rulings in three cases have gone against it.
Bayer argues that studies have established that glyphosate, Roundup’s active ingredient, is safe and made clear Friday that it stands by the product. A company statement said that “while glyphosate will continue to play an important role in agriculture and in Bayer’s portfolio, the company is committed to offering more choices for growers.”
Advertisement - story continues below
Bayer acquired Monsanto for $63 billion last year.
The Western Journal has not reviewed this Associated Press story prior to publication. Therefore, it may contain editorial bias or may in some other way not meet our normal editorial standards. It is provided to our readers as a service from The Western Journal.
We are committed to truth and accuracy in all of our journalism. Read our editorial standards.